Altman Peter
Altman Peter, PRES, reported an open-market or private purchase at BioCardia, Inc. involving 800.000000 shares for an estimated $872.00. Reported holdings after the transaction were 381985.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 03, 2026
- Filing date
- Sep 05, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 381,185 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BCDA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001437749-26-029732 Common Stock
- Transaction date
- Sep 03, 2026 Filed Sep 05, 2026, 01:30 AM · 2d delay
- Shares
- 800 sh $1.09 per share
- Estimated value
- $872 Computed from shares × price
- Holdings after
- 381,985 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+28 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - director_buy+6 points
is_director = true
Director open-market purchase. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President and CEO
- F1
This transaction was executed in multiple trades ranging from $1.09 to $1.10 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undert…
- F2
The total herein has been corrected by adding 70 shares that were inadvertently omitted from the Form 4 filed August 18, 2026.
0 other transactions
0 recent txs